GlobeNewswire by notified

Amlan International to Showcase Natural Mineral Technology at International Production and Processing Expo (IPPE)

Share

CHICAGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America, is pleased to announce its participation in the International Production and Processing Expo (IPPE) January 24-26, 2023, in Atlanta, GA. Attendees will learn more about the latest in feed technology for animal protein producers that optimize gut health through three exciting TECHTalks, a new product showcase featuring Phylox®, and two poster presentations during the International Poultry Scientific Forum (IPSF). Amlan is also proud to be the exclusive sponsor of the IPPE Media Center. Amlan looks forward to welcoming a global audience of animal production professionals and sharing more about its range of products with attendees, media and other exhibitors at its booth, B5453.

Last year at IPPE, Amlan expanded its product portfolio with the launch of Phylox (available in select international markets). Phylox is a research-backed, natural alternative to anticoccidial drugs that supports gut health naturally thus improving productivity and, in turn, driving producers' profits. This year, Phylox will be highlighted during the expo’s new product showcase. Attendees can watch a video presentation to learn more about the company’s latest innovation. 

“We look forward to speaking with producers about how Phylox, a bioactive blend of antiprotozoal phytochemicals with multiple modes of action, decreases the negative production and health effects of coccidiosis,” said Dr. Wade Robey, Vice President of Agriculture, Oil-Dri, and President, Amlan International. “Phylox is natural and can be used in “no antibiotics ever” (NAE) programs, has no withdrawal requirements, and can be fed in combination with anticoccidial vaccines preventing disease breakthrough.”

“We are excited about the success of our North American portfolio, which includes Sorbiam™ and Enterotec™. The industry reaction to these products created to optimize animal gut health has been tremendous,” according to Heath Wessels, Vice President of Sales, The Americas. “Working with our key customers, our products continue to demonstrate the efficacy of our mineral-based feed additives.” 

Attendees can learn more about the latest in protein and feed technology presented during TECHTalks.

On Tuesday, January 24:

  • Dr. Marc Herpfer, VP, New Technologies, Oil-Dri Corporation of America, will present “Natural Mineral Technology as an Alternative to AGPs” in B Hall, Booth B8675 at 11:00 a.m.
  • Dr. Josh Payne, Dir. Technical Service, Poultry Guard, will present “Best Management Practices and Utilization of Clay-Based Litter Amendment for pH and Ammonia Control” in B Hall, Booth B3646 at 11:30 a.m.

On Wednesday, January 25:

  • Mike Donohue, VP, Agri Stats, Inc. will present “The Importance of 1%, The Effect of Efficiency on Sustainability and Economic Value” in B Hall, Booth B3646 at 10:00 a.m. 

TECHTalks are an excellent way for us to provide valuable information on specific technical challenges the industry is facing,” says Dr. Aldo Rossi, Vice President, Innovation and Technical Service. “We are proud of our high-quality and efficacious mineral-based feed additives for poultry and livestock, and how they can improve the quality of animal protein. We look forward to sharing our solutions with producers.”

During the International Poultry Scientific Forum (IPSF) on January 23, Amlan experts will present two posters, selected by IPSF, detailing research designed to support optimal poultry intestinal health and bring the latest production technology to producers. The presentations will be from 4:00 p.m. to 6:00 p.m.:

  • Feeding Varium® produces growth performance similar to feeding an antibiotic on-farm, by Dr. Sara (LeAnn) Johnston, Technical Service Manager, Amlan International
  • A natural coccidiostat, Phylox Feed, improves performance, intestinal lesion scores, and fecal oocyst shedding of Eimeria-infected broilers, Dr. San (Chris) Ching, Senior Research Manager, Amlan International.

Amlan is continuing to proudly celebrate its 15th anniversary of providing natural mineral-based feed additives to the industry. The Amlan brand was introduced into the feed-additive market in 2007. Vertical integration allows Amlan to leverage Oil-Dri's mineral science expertise to develop novel, natural feed additives. Oil-Dri launched its first mineral-based product, an industrial floor absorbent, in 1941, and since then has mined and processed a range of unique minerals for many applications. Oil-Dri has been active in the animal health market since the 1980s, with products that assist feed flowability and pellet binding. 

“As the proud exclusive sponsor of the IPPE Media Center, Amlan looks forward to building relationships with media from around the world,” says Reagan Culbertson, Vice President of Strategic Marketing, B2B. “We hope media professionals will visit the Media Center to work, network and visit with our experts about Amlan’s unique and exciting mineral technology.” 

For more information on Amlan International, please visit: www.amlan.com

Company Information

Amlan is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process its unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as “Amlan International” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives across the world. Product availability may vary by country, associated claims do not constitute medical claims and may differ based on government requirements.

Reagan Culbertson
Media Contact
press@amlan.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions3.5.2024 22:39:16 CEST | Press release

CUPERTINO, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Apple Inc. has released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS OR ENTITIES WHO OR WHICH HELD SHARES OF APPLE INC. (“APPLE” OR THE “COMPANY”) COMMON STOCK AS OF THE CLOSE OF TRADING ON APRIL 29, 2024. THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A CURRENT APPLE SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS. THIS ACTION IS NOT A “CLASS ACTION.” THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR MONETARY PAYMENT. IF YOU DO NOT OBJECT TO THE TERMS OF THE PROPOSED SETTLEMENT OR THE AMOUNT OF ATTORNEYS’ FEES AND EXPENSES DESCRIBED IN THIS NOTICE, YOU ARE NOT OBLIGATED TO TAKE ANY ACTION. The purpose of this Notice is to inform you of: (i) the pendency of the shareholder derivative action brought on beh

CNH announces voting results of 2024 Annual General Meeting and publishes 2023 Sustainability Report3.5.2024 22:30:00 CEST | Press release

Basildon, May 3, 2024 CNH Industrial N.V. (NYSE: CNHI) today held its annual general meeting of shareholders. Shareholders re-appointed the Company’s director nominees, including Suzanne Heywood and Scott W. Wine as executive directors1, and Elizabeth Bastoni, Howard W. Buffett, Richard J. Kramer, Karen Linehan, Alessandro Nasi, Vagn Sørensen and Åsa Tamsons as non-executive directors. Shareholders also approved a dividend of $0.47 per common share (equivalent to a total distribution of approximately $585 million), and the AGM approved the Company’s Remuneration Policy. In other voting, shareholders appointed Deloitte Accountants B.V. as the independent auditor for the 2025 financial year and approved the Company’s 2023 financial statements prepared under IFRS. Details of all matters approved today by the AGM are available on the Company's website (www.cnh.com). *** The dividend is payable on May 29, 2024 to shareholders of record on May 13, 2024. Shareholders holding CNH common shares

Nokia Corporation: Repurchase of own shares on 03.05.20243.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 03 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 03.05.2024 Espoo, Finland – On 03 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL379,8083.44CEUX--BATE--AQEU--TQEX--Total379,8083.44 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons3.5.2024 19:48:16 CEST | Press release

Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. Details of the person discharging managerial responsibilities/person closely associated a)Name of the Board member/Executive/Associated PersonMaziar Mike Doustdar2 Reason for the notificationa)Position/statusExecutive Vice Presidentb)Initial notification/AmendmentInitial notification3 Details of the issuera)NameNovo Nordisk A/Sb)LEI549300DAQ1CVT6CXN342

Subsea 7 S.A. notification of major holding3.5.2024 18:32:01 CEST | Press release

Luxembourg –3 May 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 3 May 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: On 30 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares was 1,044,272 On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) was 13,906,019On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (b) of the Transparency Law (swaps) was 499,740 When combined, the above positions equate to 5.07% of voting r

HiddenA line styled icon from Orion Icon Library.Eye